Terrie J. Curran
Net Worth
Last updated:
What is Terrie J. Curran net worth?
The estimated net worth of Ms. Terrie J. Curran is at least $8,422,497 as of 15 Jul 2024. She owns shares worth $3,985,094 as insider, has earned $974,003 from insider trading and has received compensation worth at least $3,463,400 in Phathom Pharmaceuticals, Inc..
What is the salary of Terrie J. Curran?
Ms. Terrie J. Curran salary is $865,850 per year as Pres, Chief Executive Officer & Director in Phathom Pharmaceuticals, Inc..
How old is Terrie J. Curran?
Ms. Terrie J. Curran is 56 years old, born in 1969.
What stocks does Terrie J. Curran currently own?
As insider, Ms. Terrie J. Curran owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Phathom Pharmaceuticals, Inc. (PHAT) | Pres, Chief Executive Officer & Director | 377,734 | $10.55 | $3,985,094 |
What does Phathom Pharmaceuticals, Inc. do?
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan, which is in Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. Phathom Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Florham Park, New Jersey.
Terrie J. Curran insider trading
Phathom Pharmaceuticals, Inc.
Ms. Terrie J. Curran has made 6 insider trades between 2021-2024, according to the Form 4 filled with the SEC. Most recently she sold 33,848 units of PHAT stock worth $396,699 on 15 Jul 2024.
The largest trade she's ever made was exercising 33,848 units of PHAT stock on 15 Jul 2024. As of 15 Jul 2024 she still owns at least 377,734 units of PHAT stock.
Phathom Pharmaceuticals key executives
Phathom Pharmaceuticals, Inc. executives and other stock owners filed with the SEC:
- Dr. Azmi Nabulsi M.D., M.P.H. (66) Co-Founder & Chief Operating Officer
- Mr. David A. Socks (51) Co-Founder & Director
- Ms. Terrie J. Curran (56) Pres, Chief Executive Officer & Director